Providing further context, a German study with data from 909 newly diagnosed CLL patients found that 12.4% of those older than 70 years old harbored TP53 mutations vs. 6.4% of those younger than 70 years (p = 0.007). The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.